The FDA just approved a new drug which can slow progression of early symptoms. A couple in Kensington said this drug is ...
U.S. health officials have approved a new Alzheimer’s drug that can modestly slow the disease. It's only the second drug that ...
The FDA approved the experimental Alzheimer's drug donanemab. The drug will be sold under the brand name Kisunla.
The agency determined that the potential of slowing the devastating disease in patients with mild cognitive impairment ...
The U.S. Food and Drug Administration on Tuesday approved Eli Lilly's treatment for early Alzheimer's, making it the second ...
Click in for more news from The Hill{beacon} Health Care Health Care The Big Story New Alzheimer’s drug gets FDA approval ...
The FDA approved Eli Lilly's Alzheimer's drug, expanding treatment options for the disease in the US. It will be sold under ...
The drug will be available to adults with mild cognitive impairments in the early stages of the disease. The company that ...
Alzheimer’s drug that can slow the disease by several months. FDA approves a second Alzheimer’s drug that can slow the ...
The FDA approved Eli Lilly's drug Kisunla to treat early-stage Alzheimer's disease. Kisunla is only the second drug approved ...
The FDA approved a new drug from Eli Lilly, which will be sold under the brand name Kisunla, that has shown to modestly slow ...
The Food and Drug Administration on Tuesday approved Eli Lilly’s Alzheimer’s drug, the company announced, clearing the way ...